abstract |
The present invention provides placental perfusate, placental perfusate cells and placenta-derived intermediate natural killer (PINK) cells, and combinations thereof. The present invention also provides compositions comprising placental perfusate, placental perfusate cells, and intermediate natural killer cells from placenta and combinations thereof, and the use of placental perfusate, placental perfusate cells, and intermediates from placenta Natural killer cells and combinations thereof, methods of inhibiting the growth or proliferation of tumor cells, cancer cells, etc. and methods of treating individuals with tumor cells. In a preferred embodiment, the composition comprises: isolated CD56 + , CD16 - natural killer cells. |